ERBB2 and breast cancer: The VFA was made to quantitatively profile serological exosomes from different breast cancer subtypes through the detection of exosomal surface proteins carcinoembryonic antigen (CEA), human epidermal growth factor receptor 2 (HER2), and Mucin 1 (MUC1) [177].